Literature DB >> 13275847

Observations on the use of prednisone in patients with progressive systemic sclerosis (diffuse scleroderma).

G P RODNAN, R L BLACK, A J BOLLET, J J BUNIM.   

Abstract

Entities:  

Keywords:  SCLERODERMA/therapy; STEROIDS/therapeutic use

Mesh：

Substances：

Year:  1956        PMID： 13275847     DOI： 10.7326/0003-4819-44-1-16

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

1.  The natural course of progressive systemic sclerosis patients with interstitial lung involvement.

Authors:  Musellim Benan; Ikitimur Hande; Ongen Gul
Journal:  Clin Rheumatol       Date:  2006-04-25       Impact factor: 2.980

2.  Clinical uses and hazards of adrenal steroids and their analogues in the management of rheumatic diseases.

Authors:  J J BUNIM
Journal:  Bull N Y Acad Med       Date:  1957-07

3.  Failure of low molecular weight dextran infusions in scleroderma.

Authors:  J A Kirk; A S Dixon
Journal:  Ann Rheum Dis       Date:  1969-01       Impact factor: 19.103

4.  Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design.

Authors:  Robyn T Domsic; Shiyao Gao; Maureen Laffoon; Steven Wisniewski; Yuqing Zhang; Virginia Steen; Robert Lafyatis; Thomas A Medsger
Journal:  Rheumatology (Oxford)       Date:  2021-10-02       Impact factor: 7.580
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.